Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Cutter

Showing results (121-130 of 333) with videos related to

Pageof 34
Sort By:
Disability and Health Journal|July 1, 2021
Physical activity and self-reported sleep quality in adults with multiple sclerosisKatie L J Cederberg, Brenda Jeng, Jeffer E Sasaki, et al.
Neurology|December 8, 2017
Diet quality is associated with disability and symptom severity in multiple sclerosisKathryn C Fitzgerald, Tuula Tyry, Amber Salter, et al.
Annals of the New York Academy of Sciences|January 3, 2013
Biomarker development for myasthenia gravisHenry J Kaminski, Linda L Kusner, Gil I Wolfe, et al.
American Journal of Physiology. Renal Physiology|September 20, 2014
Distinct populations of label-retaining cells in the adult kidney are defined temporally and exhibit divergent regional distributionsSunil Rangarajan, Bhuvana Sunil, Chunlan Fan, et al.
Neurology|August 11, 2021
Association of Age With Contrast-Enhancing Lesions Across the Multiple Sclerosis Disease SpectrumMarcus W Koch, Jop Mostert, Yinan Zhang, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|September 27, 2024
Prevalence of restless legs and association with patient-reported outcome measures in myasthenia gravisMohanad AlGaeed, Tarrant McPherson, Ikjae Lee, et al.
Epilepsy & Behavior : E&B|July 17, 2021
Longitudinal impact of cannabidiol on EEG measures in subjects with treatment-resistant epilepsyLeslie Grayson, Steve Ampah, Kathleen Hernando, et al.
Journal of Neurology|May 15, 2022
The timed 25-foot walk is a more sensitive outcome measure than the EDSS for PPMS trials: an analysis of the PROMISE clinical trial datasetMarcus W Koch, Jop Mostert, Pavle Repovic, et al.
Annals of Clinical and Translational Neurology|February 6, 2020
Visual spatial learning outcomes for clinical trials in neurofibromatosis type 1Nicole J Ullrich, Jonathan M Payne, Karin S Walsh, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 14, 2015
The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic reviewRuth Ann Marrie, Stephen Reingold, Jeffrey Cohen, et al.
Pageof 34

Showing results (121-130 of 333) with videos related to

Sort By:
Pageof 34
Disability and Health Journal|July 1, 2021
Physical activity and self-reported sleep quality in adults with multiple sclerosisKatie L J Cederberg, Brenda Jeng, Jeffer E Sasaki, et al.
Neurology|December 8, 2017
Diet quality is associated with disability and symptom severity in multiple sclerosisKathryn C Fitzgerald, Tuula Tyry, Amber Salter, et al.
Annals of the New York Academy of Sciences|January 3, 2013
Biomarker development for myasthenia gravisHenry J Kaminski, Linda L Kusner, Gil I Wolfe, et al.
American Journal of Physiology. Renal Physiology|September 20, 2014
Distinct populations of label-retaining cells in the adult kidney are defined temporally and exhibit divergent regional distributionsSunil Rangarajan, Bhuvana Sunil, Chunlan Fan, et al.
Neurology|August 11, 2021
Association of Age With Contrast-Enhancing Lesions Across the Multiple Sclerosis Disease SpectrumMarcus W Koch, Jop Mostert, Yinan Zhang, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|September 27, 2024
Prevalence of restless legs and association with patient-reported outcome measures in myasthenia gravisMohanad AlGaeed, Tarrant McPherson, Ikjae Lee, et al.
Epilepsy & Behavior : E&B|July 17, 2021
Longitudinal impact of cannabidiol on EEG measures in subjects with treatment-resistant epilepsyLeslie Grayson, Steve Ampah, Kathleen Hernando, et al.
Journal of Neurology|May 15, 2022
The timed 25-foot walk is a more sensitive outcome measure than the EDSS for PPMS trials: an analysis of the PROMISE clinical trial datasetMarcus W Koch, Jop Mostert, Pavle Repovic, et al.
Annals of Clinical and Translational Neurology|February 6, 2020
Visual spatial learning outcomes for clinical trials in neurofibromatosis type 1Nicole J Ullrich, Jonathan M Payne, Karin S Walsh, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 14, 2015
The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic reviewRuth Ann Marrie, Stephen Reingold, Jeffrey Cohen, et al.
Pageof 34